332 related articles for article (PubMed ID: 15677495)
1. Portal venous 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside infusion overcomes hyperinsulinemic suppression of endogenous glucose output.
Camacho RC; Pencek RR; Lacy DB; James FD; Donahue EP; Wasserman DH
Diabetes; 2005 Feb; 54(2):373-82. PubMed ID: 15677495
[TBL] [Abstract][Full Text] [Related]
2. 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside renders glucose output by the liver of the dog insensitive to a pharmacological increment in insulin.
Camacho RC; Lacy DB; James FD; Donahue EP; Wasserman DH
Am J Physiol Endocrinol Metab; 2005 Dec; 289(6):E1039-43. PubMed ID: 16046457
[TBL] [Abstract][Full Text] [Related]
3. 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside causes acute hepatic insulin resistance in vivo.
Pencek RR; Shearer J; Camacho RC; James FD; Lacy DB; Fueger PT; Donahue EP; Snead W; Wasserman DH
Diabetes; 2005 Feb; 54(2):355-60. PubMed ID: 15677492
[TBL] [Abstract][Full Text] [Related]
4. Effect of 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside infusion on in vivo glucose and lipid metabolism in lean and obese Zucker rats.
Bergeron R; Previs SF; Cline GW; Perret P; Russell RR; Young LH; Shulman GI
Diabetes; 2001 May; 50(5):1076-82. PubMed ID: 11334411
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of insulin-mediated rat muscle glucose uptake and microvascular perfusion by 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside.
Bradley EA; Zhang L; Genders AJ; Richards SM; Rattigan S; Keske MA
Cardiovasc Diabetol; 2015 Jul; 14():91. PubMed ID: 26194188
[TBL] [Abstract][Full Text] [Related]
6. AICAR administration causes an apparent enhancement of muscle and liver insulin action in insulin-resistant high-fat-fed rats.
Iglesias MA; Ye JM; Frangioudakis G; Saha AK; Tomas E; Ruderman NB; Cooney GJ; Kraegen EW
Diabetes; 2002 Oct; 51(10):2886-94. PubMed ID: 12351423
[TBL] [Abstract][Full Text] [Related]
7. Impact of in vivo fatty acid oxidation blockade on glucose turnover and muscle glucose metabolism during low-dose AICAR infusion.
Christopher M; Rantzau C; Chen ZP; Snow R; Kemp B; Alford FP
Am J Physiol Endocrinol Metab; 2006 Nov; 291(5):E1131-40. PubMed ID: 16772328
[TBL] [Abstract][Full Text] [Related]
8. Suppression of endogenous glucose production by mild hyperinsulinemia during exercise is determined predominantly by portal venous insulin.
Camacho RC; Pencek RR; Lacy DB; James FD; Wasserman DH
Diabetes; 2004 Feb; 53(2):285-93. PubMed ID: 14747277
[TBL] [Abstract][Full Text] [Related]
9. Potential role for AMP-activated protein kinase in hypoglycemia sensing in the ventromedial hypothalamus.
McCrimmon RJ; Fan X; Ding Y; Zhu W; Jacob RJ; Sherwin RS
Diabetes; 2004 Aug; 53(8):1953-8. PubMed ID: 15277372
[TBL] [Abstract][Full Text] [Related]
10. Interaction of exercise, insulin, and hypoglycemia studied using euglycemic and hypoglycemic insulin clamps.
Zinker BA; Allison RG; Lacy DB; Wasserman DH
Am J Physiol; 1997 Apr; 272(4 Pt 1):E530-42. PubMed ID: 9142871
[TBL] [Abstract][Full Text] [Related]
11. A negative arterial-portal venous glucose gradient decreases skeletal muscle glucose uptake.
Galassetti P; Shiota M; Zinker BA; Wasserman DH; Cherrington AD
Am J Physiol; 1998 Jul; 275(1):E101-11. PubMed ID: 9688880
[TBL] [Abstract][Full Text] [Related]
12. 5-Aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAR) effect on glucose production, but not energy metabolism, is independent of hepatic AMPK in vivo.
Hasenour CM; Ridley DE; Hughey CC; James FD; Donahue EP; Shearer J; Viollet B; Foretz M; Wasserman DH
J Biol Chem; 2014 Feb; 289(9):5950-9. PubMed ID: 24403081
[TBL] [Abstract][Full Text] [Related]
13. Contrasting effects of exercise, AICAR, and increased fatty acid supply on in vivo and skeletal muscle glucose metabolism.
Rantzau C; Christopher M; Alford FP
J Appl Physiol (1985); 2008 Feb; 104(2):363-70. PubMed ID: 18032581
[TBL] [Abstract][Full Text] [Related]
14. AMPK activation with AICAR provokes an acute fall in plasma [K+].
Zheng D; Perianayagam A; Lee DH; Brannan MD; Yang LE; Tellalian D; Chen P; Lemieux K; Marette A; Youn JH; McDonough AA
Am J Physiol Cell Physiol; 2008 Jan; 294(1):C126-35. PubMed ID: 18003746
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of insulin-stimulated glycogen synthesis by 5-aminoimidasole-4-carboxamide-1-beta-d-ribofuranoside-induced adenosine 5'-monophosphate-activated protein kinase activation: interactions with Akt, glycogen synthase kinase 3-3alpha/beta, and glycogen synthase in isolated rat soleus muscle.
Fediuc S; Gaidhu MP; Ceddia RB
Endocrinology; 2006 Nov; 147(11):5170-7. PubMed ID: 16873531
[TBL] [Abstract][Full Text] [Related]
16. 5-aminoimidazole-4-carboxamide 1-beta-D-ribofuranoside acutely stimulates skeletal muscle 2-deoxyglucose uptake in healthy men.
Cuthbertson DJ; Babraj JA; Mustard KJ; Towler MC; Green KA; Wackerhage H; Leese GP; Baar K; Thomason-Hughes M; Sutherland C; Hardie DG; Rennie MJ
Diabetes; 2007 Aug; 56(8):2078-84. PubMed ID: 17513706
[TBL] [Abstract][Full Text] [Related]
17. Hypothalamic AMP-activated protein kinase activation with AICAR amplifies counterregulatory responses to hypoglycemia in a rodent model of type 1 diabetes.
Fan X; Ding Y; Brown S; Zhou L; Shaw M; Vella MC; Cheng H; McNay EC; Sherwin RS; McCrimmon RJ
Am J Physiol Regul Integr Comp Physiol; 2009 Jun; 296(6):R1702-8. PubMed ID: 19357294
[TBL] [Abstract][Full Text] [Related]
18. A comparison of the effects of selective increases in peripheral or portal insulin on hepatic glucose production in the conscious dog.
Sindelar DK; Balcom JH; Chu CA; Neal DW; Cherrington AD
Diabetes; 1996 Nov; 45(11):1594-604. PubMed ID: 8866566
[TBL] [Abstract][Full Text] [Related]
19. Prior exercise and the response to insulin-induced hypoglycemia in the dog.
Koyama Y; Galassetti P; Coker RH; Pencek RR; Lacy DB; Davis SN; Wasserman DH
Am J Physiol Endocrinol Metab; 2002 May; 282(5):E1128-38. PubMed ID: 11934679
[TBL] [Abstract][Full Text] [Related]
20. Portal infusion of escitalopram enhances hepatic glucose disposal in conscious dogs.
An Z; Moore MC; Winnick JJ; Farmer B; Neal DW; Lautz M; Smith M; Rodewald T; Cherrington AD
Eur J Pharmacol; 2009 Apr; 607(1-3):251-7. PubMed ID: 19326481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
